Risk stratification of childhood infection using host markers of immune and endothelial activation in Asia (Spot Sepsis): a multi-country, prospective, cohort study.
Chandna A. et al, (2025), Lancet Child Adolesc Health, 9, 634 - 645
Case Report: Genetic evolution of Burkholderia pseudomallei during treatment leading to antibiotic resistance and disease relapse.
Evans TJ. et al, (2025), Wellcome Open Research, 10, 281 - 281
Case Report: Genetic evolution of Burkholderia pseudomallei during treatment leading to antibiotic resistance and disease relapse – a case report.
Evans TJ. et al, (2025), Wellcome Open Research, 10, 281 - 281
Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19
Schilling WHK. et al, (2025)
Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV).
Jittamala P. et al, (2025), EClinicalMedicine, 80
AmpC β-lactamases detected in Southeast Asian Escherichia coli and Klebsiella pneumoniae.
Roberts T. et al, (2024), JAC Antimicrob Resist, 6
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.
Schilling WHK. et al, (2024), PLoS Med, 21
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV).
Wongnak P. et al, (2024), Lancet Infect Dis, 24, 953 - 963
Genetic diversity, determinants, and dissemination of Burkholderia pseudomallei lineages implicated in melioidosis in Northeast Thailand.
Seng R. et al, (2024), Nat Commun, 15
Melioidosis in Patients with COVID-19 Exposed to Contaminated Tap Water, Thailand, 2021.
Tantirat P. et al, (2024), Emerg Infect Dis, 30, 791 - 794
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial.
Schilling WHK. et al, (2024), Lancet Infect Dis, 24, 36 - 45
Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV).
Jittamala P. et al, (2023), J Infect Dis, 228, 1318 - 1325
Diversity of Human Enterovirus Co-Circulations in Five Kindergartens in Bangkok between July 2019 and January 2020.
Sittikul P. et al, (2023), Viruses, 15
Molecular diagnosis and genotyping of Orientia tsutsugamushi in Maesot and Chiangrai, Thailand.
Rungrojn A. et al, (2023), Front Trop Dis, 4